James Patrick Kelly, EVP & Chief Financial Officer at Vanda Pharmaceuticals Inc. (VNDA), sold 27,454 shares at $20.15 ($548K) on 2019-03-01, disclosed to the SEC on 2019-03-04.
Open-market sale of $548k VNDA by EVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.15 | 4,976 | $100K | 18.3% |
| 2 | $20.15 | 4,976 | $100K | 18.3% |
| 3 | $19.88 | 8,751 | $174K | 31.7% |
| 4 | $19.88 | 8,751 | $174K | 31.7% |
| Total | $19.98 avg | 27,454 | $548K | 100% |
| Filing → |
| VNDA | SELL | 2019-01-04 | $232K | — | Filing → |
| CBT | SELL | 2018-06-08 | $160K | — | Filing → |
| VNDA | SELL | 2018-03-02 | $319K | — | Filing → |